Research Article

Cancer-Derived Exosomal miR-651 as a Diagnostic Marker Restrains Cisplatin Resistance and Directly Targets ATG3 for Cervical Cancer

Figure 5

Upregulation of ATG3 in cervical cancer. (a) Box plot for ATG3 expression in cervical cancer and normal tissue specimens from TCGA database. (b) Comparisons of ATG3 expression in normal and different stages of cervical cancer tissues. (c) Expression of ATG3 in cervical cancer tissues based on nodal metastasis status. (d, e) Western blot for ATG3 expression in cervical cancer as well as normal plasma samples. (f) Expression of ATG3 in cervical cancer and normal plasma samples via RT-qPCR. (g) Correlation between circulating miR-651 and ATG3 among cervical cancer subjects. ; .
(a)
(b)
(c)
(d)
(e)
(f)
(g)